- 2 Results
Lowest price: € 109.00, highest price: € 173.95, average price: € 141.48
1
Order
at Indigo.ca
(aprox. € 173.95)
OrderSponsored link

Cancer Pharmacogenetics - new book

ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… More...

Shipping costs:plus shipping costs
2
Order
at bol.com
€ 109.00
OrderSponsored link

Springer-Verlag New York Inc.:

Cancer Pharmacogenetics - new book

2008, ISBN: 9780387691336

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the internation… More...

  - Nieuw, Vermoedelijk 4-6 weken Shipping costs:Vermoedelijk 4-6 weken, plus shipping costs bol.com

1As some platforms do not transmit shipping conditions to us and these may depend on the country of delivery, the purchase price, the weight and size of the item, a possible membership of the platform, a direct delivery by the platform or via a third-party provider (Marketplace), etc., it is possible that the shipping costs indicated by euro-book.co.uk / euro-book.co.uk do not correspond to those of the offering platform.

Bibliographic data of the best matching book

Details of the book

The field of pharmacogenetics has expanded rapidly over the past few years since the release of the working draft of the human genome project and the continuing efforts of the international HapMap project. Cancer therapy offers an ideal scenario for the integration of pharmacogenetics into clinical practice - often there are multiple treatment options but a finite window of time to select the correct one. The ideal of testing patients for genetic markers for chemotherapy efficacy and/or toxicity is becoming a reality with FDA approved clinical tests and genotype-guided clinical trials. This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice. TOC:A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics

Details of the book - Cancer Pharmacogenetics


EAN (ISBN-13): 9780387691336
ISBN (ISBN-10): 0387691332
Publishing year: 2008
Publisher: Springer

Book in our database since 2008-03-03T07:33:19+00:00 (London)
Detail page last modified on 2017-02-01T20:28:53+00:00 (London)
ISBN/EAN: 9780387691336

ISBN - alternate spelling:
0-387-69133-2, 978-0-387-69133-6
Alternate spelling and related search-keywords:
Book title: pharmacogenetics, cancer


Information from Publisher

Author: Sharon Marsh
Title: Cancer Pharmacogenetics
Publisher: Springer; Springer US
280 Pages
Publishing year: 2010-06-15
New York; NY; US
Language: English
112,30 € (DE)
115,45 € (AT)
150,65 CHF (CH)
Not available, publisher indicates OP

BB; Book; Hardcover, Softcover / Medizin/Nichtklinische Fächer; Onkologie; cancer therapy; genetics; chemotherapy; toxicity; cancer treatment; drug; leukemia; pharmacodynamics; research; pharmacokinetics; clinical trial; cancer; kinetics; B; Cancer Research; Biomedical and Life Sciences; Pharmacology/Toxicology; Health Promotion and Disease Prevention; Epidemiology; Medical Microbiology; Pharmakologie; Public Health und Präventivmedizin; Epidemiologie und medizinische Statistik; Mikrobiologie und Virologie; EA

A History of Pharmacogenetics.- Pharmacokinetics and pharmacogenetics.- drug targets and pharmacogenetics.- Pharmacodynamics and pharmacogenetics.- toxicity and pharmacogentics.- Leukemia: the TPMT Example.- Solid tumors I: The UGT1A1 Example.- Solid Tumors II: the EGFR Example.- Novel Pharmacogenetic markers: whole genome association studies.- In silico resources for cancer pharmacogenetics: databases and knowledge bases.- pharmacogenetics methodology-overview of available methods.- From bedside to clinical practice I: Clinical trials.- From Bedside to Clinical Practice II: FDA.- The Future of Cancer Pharmacogenetics
This volume is designed to offer an overview of the role of pharmacogenetics in cancer treatment, from the history of the field through to its integration into clinical practice.

< to archive...